Maya Tchikviladze

Suresnes, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

Differences in Use of Disease-Modifying Therapies Between Patients With Late-Onset and Adult-Onset Relapsing-Remitting Multiple Sclerosis.

Differences in Use of Disease-Modifying Therapies Between Patients With Late-Onset and Adult-Onset Relapsing-Remitting Multiple Sclerosis.

Journal: Neurology
Published: May 05, 2026

Sex-Related Gap in the Use of Disease-Modifying Therapies in Multiple Sclerosis.

Sex-Related Gap in the Use of Disease-Modifying Therapies in Multiple Sclerosis.

Journal: Neurology
Published: July 30, 2025

Progression independent of relapse and MRI activity and treatment strategies in multiple sclerosis.

Progression independent of relapse and MRI activity and treatment strategies in multiple sclerosis.

Journal: Brain : a journal of neurology
Published: July 21, 2025

Use of Disease-Modifying Therapies in Patients With Late-Onset Multiple Sclerosis.

Use of Disease-Modifying Therapies in Patients With Late-Onset Multiple Sclerosis.

Journal: Neurology
Published: July 16, 2025

Clinical and genetic keys to cerebellar ataxia due to FGF14 GAA expansions.

Clinical and genetic keys to cerebellar ataxia due to FGF14 GAA expansions.

Journal: EBioMedicine
Published: October 02, 2023

Motor neuron involvement threatens survival in spinocerebellar ataxia type 1.

Motor neuron involvement threatens survival in spinocerebellar ataxia type 1.

Journal: Neuropathology and applied neurobiology
Published: August 05, 2022

Intermediate repeat expansions of TBP and STUB1: Genetic modifier or pure digenic inheritance in spinocerebellar ataxias?

Intermediate repeat expansions of TBP and STUB1: Genetic modifier or pure digenic inheritance in spinocerebellar ataxias?

Journal: Genetics in medicine : official journal of the American College of Medical Genetics
Published: June 29, 2022

Quantitative neuroimaging biomarkers in a series of 20 adult patients with POLG mutations.

Quantitative neuroimaging biomarkers in a series of 20 adult patients with POLG mutations.

Journal: Mitochondrion
Published: March 26, 2017

Low cancer prevalence in polyglutamine expansion diseases.

Low cancer prevalence in polyglutamine expansion diseases.

Journal: Neurology
Published: July 11, 2016

Dynamic Imaging of Individual Remyelination Profiles in Multiple Sclerosis.

Dynamic Imaging of Individual Remyelination Profiles in Multiple Sclerosis.

Journal: Annals of neurology
Published: May 26, 2015

Nocturnal agitation in Huntington disease is caused by arousal-related abnormal movements rather than by rapid eye movement sleep behavior disorder.

Nocturnal agitation in Huntington disease is caused by arousal-related abnormal movements rather than by rapid eye movement sleep behavior disorder.

Journal: Sleep medicine
Published: September 02, 2014

A diagnostic flow chart for POLG-related diseases based on signs sensitivity and specificity.

A diagnostic flow chart for POLG-related diseases based on signs sensitivity and specificity.

Journal: Journal of neurology, neurosurgery, and psychiatry
Published: September 20, 2013
Showing 1-12 of 13

Last Updated: 09/26/2026